Metabolic hormones, such as leptin, alter the input organization of hypothalamic circuits, resulting in increased pro-opiomelanocortin (POMC) tone, followed by decreased food intake and adiposity. The gonadal steroid estradiol can also reduce appetite and adiposity, and it influences synaptic plasticity. Here we report that estradiol (E2) triggers a robust increase in the number of excitatory inputs to POMC neurons in the arcuate nucleus of wild-type rats and mice. This rearrangement of synapses in the arcuate nucleus is leptin independent because it also occurred in leptin-deficient (ob/ob) and leptin receptor-deficient (db/db) mice, and was paralleled by decreased food intake and body weight gain as well as increased energy expenditure. However, estrogen-induced decrease in body weight was dependent on Stat3 activation in the brain. These observations support the notion that synaptic plasticity of arcuate nucleus feeding circuits is an inherent element in body weight regulation and offer alternative approaches to reducing adiposity under conditions of failed leptin receptor signaling.

Dopamine (DA)-containing projections to the cerebral cortex are considered to play an important role in cognitive processes. Using a recently developed monoclonal antiserum directed against DA and an antibody directed against tyrosine hydroxylase in combination with Golgi impregnation and electron microscopy, we have observed that DA and tyrosine hydroxylase afferents establish symmetric membrane specializations with the soma, dendritic shafts, and spines of identified pyramidal cells in the prefrontal, cingulate, and motor cortex of primates. The axospinous contacts invariably formed part of a synaptic complex in which the dendritic spine of a pyramidal neuron was the target of both a DApositive symmetric and an unlabeled asymmetric bouton. This arrangement allows direct DA modulation of the overall excitability of cortical projection neurons by altering local spine responses to excitatory inputs. Dopamine (DA) has been implicated in a wide range of cognitive and affective behaviors and its importance for diseases affecting thought processes, such as schizophrenia, has been repeatedly stressed (1). Although the highest brain concentrations of DA are found in the caudate nucleus, this neurotransmitter is also present in the cerebral cortex, particularly in areas like the prefrontal cortex (2, 3) that are involved in emotional and cognitive processing. In rodents (4) and nonhuman primates (5), experimental depletion of DA has, in fact, been shown to result in cognitive deficits.A more complete understanding of DA's role in cortical function will require detailed knowledge about the cortical targets of DA afferents. The DA innervation of the primate prefrontal cortex has so far been studied only at the light microscopic level (6, 7). These studies reveal rich plexuses of DA-containing fibers in specific layers of the prefrontal cortex in monkeys (6, 7) and humans (8). However, definitive information on the postsynaptic structures innervated by these fibers is lacking. Accordingly, the goal of the present study was to provide ultrastructural data on the nature, distribution, and postsynaptic targets of dopaminergic boutons in the primate neocortex. We have used a recently available monoclonal antiserum directed against DA developed in one of our laboratories (9) as well as an antibody to its rate-limiting enzyme, tyrosine hydroxylase (TH) (10), and combined these methods with Golgi impregnation and electron microscopy (EM) to visualize DA synapses in the primate cortex. MATERIALS AND METHODSFive adult male rhesus monkey (Macaca mulatta) were deeply anesthetized and transcardially perfused using the fixative of Van Eden et al. (11) for DA and that of Somogyi and Takagi (12) for TH. After perfusion, blocks of tissue were taken from the dorsal bank of the principal sulcus (Walker's area 46), the anterior cingulate gyrus (Brodmann's area 24), and the primary motor cortex (Brodmann's area 4) (see Fig. 1) and were then sectioned perpendicular to the pial surface on a vibratome or cryostat. The sections were stai...

No abstract

Background-Although it has been postulated for many years that depression is associated with loss of synapses, primarily in the hippocampus, and that antidepressants facilitate synapse growth, we still lack ultrastructural evidence that changes in depressive behavior are indeed correlated with structural synaptic modifications.

Previous studies have demonstrated that estradiol-17beta and estradiol-17alpha both induce short-latency effects on spatial memory in rats, estradiol-17alpha being at least as potent as its 17beta isomer. To determine whether the mechanisms underlying these behavioral responses might include effects on hippocampal synaptic plasticity, CA1 pyramidal spine synapse density (PSSD) was measured in ovariectomized rats within the first few hours after s.c. estrogen injection. PSSD increased markedly (by 24%) 4.5 h after the administration of 45 microg/kg estradiol-17beta. The PSSD response was significantly greater (44% above control) 30 min after estradiol-17beta injection and was markedly dose dependent; a 3-fold lower estradiol-17beta dose (15 microg/kg) did not significantly affect CA1 PSSD at either 30 min or 4.5 h. Estradiol-17alpha was a more potent inducer of PSSD than estradiol-17beta. Dose-response analysis determined an ED50 for the effect of estradiol-17alpha on PSSD of 8.92 +/- 1.99 microg/kg, with a maximal response at 15 microg/kg. These results demonstrate that high doses of estradiol induce rapid changes in CA1 PSSD. CA1 spine synapse formation appears to be more sensitive to estradiol-17alpha than to estradiol-17beta, paralleling previous data on the effects of these two steroids on spatial memory. Rapid remodeling of hippocampal synaptic connections may thus contribute to the enhancement of spatial mnemonic processing observed within the first few hours after estrogen treatment. The potency of estradiol-17alpha suggests that hormone replacement therapy using this steroid might be useful clinically in ameliorating the impact of low endogenous estrogen production on the development and progression of neurodegenerative disorders involving the hippocampus.